Clinical Trial

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
TRACOMDD study is a study with the intention to describe the real-world use of trazodone and the clinical response in a sub-group of patients affected by Major Depressive Disorder and Mild Cognitive impairment, by collecting data from standard clinical practice in Italy, Poland, and Romania
Trial Details
NCT Number NCT07377682
Lead Sponsor Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborators: IQVIA Pty Ltd
Conditions Depression - Major Depressive Disorder, Cognition Disorders in Old Age
Enrollment 120 participants
Start Date 2025-12-15
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-30